In this issue:
KTE-X19 for R/R B-cell ALL
Ibrutinib + venetoclax for first-line CLL
Hyper-CVAD + ofatumumab for Ph- ALL
Surveillance imaging in FL
Multi-hit TP53 CLL treated with ibrutinib
Paediatric-inspired chemo with pegaspargase for Ph- ALL
Genetic identification of AML patients achieving long-term survival
Rituximab biosimilars in DLBCL
Imatinib vs imatinib + cytarabine or PegIFNα2a for CML
QOL with venetoclax-obinutuzumab for CLL
Please login below to download this issue (PDF)